FDA.reportPublic FDA data

Yorvipath 420 MCG in 1.4 ML Pen Injector

RxCUI
2693648
RxNorm name
Yorvipath 420 MCG in 1.4 ML Pen Injector
Display name
Yorvipath 420 MCG in 1.4 ML Pen Injector
Full name
Yorvipath 420 MCG in 1.4 ML Pen Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YorvipathPALOPEGTERIPARATIDEAscendis Pharma, Endocrinology, Inc.a1fa23fd-c434-443e-9a17-5750578c86022026-08-12Warnings, Adverse reactionsExact identifier
rxcui: 2693648

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a1fa23fd-c434-443e-9a17-5750578c8602Yorvipath 420 MCG in 1.4 ML Pen Injector [PSN] · 1.4 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] [SBD] · 1.4 ML Yorvipath 0.3 MG/ML Pen Injector [SY] · Yorvipath 420 MCG per 1.4 ML Pen Injector [SY]47These highlights do not include all the information needed to use YORVIPATH safely and effectively. See full prescribing information for YORVIPATH. YORVIPATH ® (palopegteriparatide) injection, for subcutaneous use Initial U.S. Approval: 202420260421